Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8568714
Lys K endolysin is synergistic with lysostaphin against MRSA
granted patentUS 8556882
Inducible interleukin-12
granted patentUS 8557844
Substrate reduction therapy
granted patentUS 8557788
Prevention of tissue ischemia and related compositions
granted patentUS 8551936
Defensin-antigen fusion proteins
granted patentUS 8545888
Tendon stem cells
granted patentUS 8546524
Smoothened polypeptides and methods of use
granted patentUS 8546091
AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
granted patentUS 8536148
Disabling autophagy as a treatment for lysosomal storage diseases
granted patentUS 8530626
Methods to produce keratin elastomer
granted patentUS 8530167
Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
granted patentUS 8524248
Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma
granted patentUS 8524239
Photosensitizing antibody-fluorophore conjugates
granted patentUS 8518957
Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing in
granted patentUS 8518968
Hydrazone and diacyl hydrazine compounds and methods of use
granted patentUS 8512991
Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, composition
granted patentUS 8506961
Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephal
granted patentUS 8501912
Filipil compositions and methods for treating cancer
granted patentUS 8501688
SCGB3A2 as a growth factor and anti-apoptotic agent
granted patentUS 8497249
Fungicidal properties of three saponins from Capsicum frutescens
granted patentUS 8486699
Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines
granted patentUS 8481255
Scytovirin domain 1 related polypeptides
granted patentUS 8481289
Triple acting antimicrobials that are refractory to resistance development
granted patentUS 8470888
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer
granted